EARLY SERUM HEPATITIS B VIRUS LARGE SURFACE PROTEIN LEVEL: A STRONG PREDICTOR OF VIROLOGICAL RESPONSE FOR PEGINTERFERON, BUT NOT FOR ENTECAVIR, IN HBeAg-POSITIVE CHRONIC HEPATITIS B

被引：0

作者：

Zhu, X. J. ^{[1
]}

Gong, Q. M. ^{[1
]}

Yu, D. M. ^{[1
]}

Zhang, D. H. ^{[1
]}

Gu, L. L. ^{[1
]}

Han, Y. ^{[1
]}

Chen, J. ^{[1
]}

Zhang, X. X. ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Dept Infect Dis, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2013年 / 58卷

关键词：

D O I：

10.1016/S0168-8278(13)60785-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

783

引用

页码：S319 / S319

页数：1

共 50 条

[31] Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: A meta-analysis [J].

Qi-Min Su .

World Journal of Gastroenterology, 2012, (43) :6290-6301

[32] PRESENCE OF PRECORE AND CORE PROMOTER MUTANTS LIMITS THE PROBABILITY OF ACHIEVING A SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON IN HBEAG-POSITIVE CHRONIC HEPATITIS B [J].

Sonneveld, Milan J. ;

Wong, Vincent W. ;

Zeuzem, Stefan ;

Heathcote, E. Jenny ;

Chan, Hoi-Yun ;

Pas, Suzan D. ;

Wong, Grace ;

Hansen, Bettina E. ;

Chan, Henry Lik-Yuen ;

Janssen, Harry L. .

HEPATOLOGY, 2011, 54 :1024A-1024A

[33] Peginterferon and Chinese herbs exert a combinatorial effect in HBeAg-positive chronic hepatitis B [J].

An, Yingfeng ;

Gao, Shoucui ;

Cheng, Daxin ;

Wang, Xiaojing ;

Bai, Liang ;

Liu, Enqi ;

Chu, Yonglie ;

Zhao, Sihai .

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (04) :369-376

[34] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients [J].

Keshvari, Maryam ;

Alavian, Seyed Moayed ;

Sharafi, Heidar .

JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)

[35] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B [J].

Lau, GKK ;

Piratvisuth, T ;

Luo, KX ;

Marcellin, P ;

Thongsawat, S ;

Cooksley, G ;

Gane, E ;

Fried, MW ;

Chow, WC ;

Paik, SW ;

Chang, WY ;

Berg, T ;

Flisiak, R ;

McCloud, P ;

Pluck, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2682-2695

[36] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B [J].

Peng, Cheng-Yuan ;

Shih, Chao-Jen ;

Lo, Pei-Shuan ;

Huang, Chia-Lin ;

Lai, Hsueh-Chou ;

Su, Wen-Pang ;

Chuang, Po-Heng ;

Kao, Jung-Ta .

HEPATOLOGY, 2011, 54 :1027A-1028A

[37] Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B [J].

Sonneveld, Milan J. ;

Wong, Vincent W-S. ;

Woltman, Andrea M. ;

Wong, Grace L. H. ;

Cakaloglu, Yilmaz ;

Zeuzem, Stefan ;

Buster, Erik H. C. J. ;

Uitterlinden, Andre G. ;

Hansen, Bettina E. ;

Chan, Henry L. Y. ;

Janssen, Harry L. A. .

GASTROENTEROLOGY, 2012, 142 (03) :513-U165

[38] Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B [J].

Chuaypen, Natthaya ;

Posuwan, Nawarat ;

Payungporn, Sunchai ;

Tanaka, Yasuhito ;

Shinkai, Noboru ;

Poovorawan, Yong ;

Tangkijvanich, Pisit .

LIVER INTERNATIONAL, 2016, 36 (06) :827-836

[39] Baseline serum WFA+-M2BP level is a strong predictor of response to pegylated interferon-α in HBeAg-positive chronic hepatitis B patients [J].

Zhu, M. ;

Huang, W. ;

Chen, Y. ;

Han, Y. ;

Gong, Q. ;

Chen, P. ;

Zhang, Y. ;

Yao, L. ;

Zhang, X. .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S481-S481

[40] Interferon-α for HBeAg-positive chronic hepatitis B [J].

Craxì, A ;

Di Bona, D ;

Cammà, C .

JOURNAL OF HEPATOLOGY, 2003, 39 :S99-S105

← 1 2 3 4 5 →